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Abstract 
Background: Cystoviruses have a phospholipid envelope around their nucleocapsid. Such a feature is unique among 
bacterial viruses (i.e., bacteriophages) and the mechanisms of virion envelopment within a bacterial host are largely 
unknown. The cystovirus Pseudomonas phage phi6 has an envelope that harbors five viral membrane proteins and 
phospholipids derived from the cytoplasmic membrane of its Gram-negative host. The phi6 major envelope protein 
P9 and the non-structural protein P12 are essential for the envelopment of its virions. Co-expression of P9 and P12 in 
a Pseudomonas host results in the formation of intracellular vesicles that are potential intermediates in the phi6 virion 
assembly pathway. This study evaluated the minimum requirements for the formation of phi6-specific vesicles and 
the possibility to localize P9-tagged heterologous proteins into such structures in Escherichia coli.
Results: Using transmission electron microscopy, we detected membranous structures in the cytoplasm of E. coli 
cells expressing P9. The density of the P9-specific membrane fraction was lower (approximately 1.13 g/cm3 in sucrose) 
than the densities of the bacterial cytoplasmic and outer membrane fractions. A P9-GFP fusion protein was used to 
study the targeting of heterologous proteins into P9 vesicles. Production of the GFP-tagged P9 vesicles required P12, 
which protected the fusion protein against proteolytic cleavage. Isolated vesicles contained predominantly P9-GFP, 
suggesting selective incorporation of P9-tagged fusion proteins into the vesicles.
Conclusions: Our results demonstrate that the phi6 major envelope protein P9 can trigger formation of cytoplasmic 
membrane structures in E. coli in the absence of any other viral protein. Intracellular membrane structures are rare in 
bacteria, thus making them ideal chasses for cell-based vesicle production. The possibility to locate heterologous pro-
teins into the P9-lipid vesicles facilitates the production of vesicular structures with novel properties. Such products 
have potential use in biotechnology and biomedicine.
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Background
Vesicles are spherical membrane structures composed of 
a lipid bilayer enclosing aqueous material. The bilayer is 
composed of phospholipids and is typically embedded 
with membrane proteins. The inner fluid can contain 
cargo molecules such as nucleic acids or soluble proteins. 
Eukaryotic cells have elaborate cell signaling and traffick-
ing systems based on different kinds of vesicle structures 
and membrane organelles. In contrast, vesicles and other 
inner membrane structures are rare in bacteria. Exam-
ples of cytoplasmic membrane organelles in bacteria 
include thylakoids, the photosynthetic membranes of 
cyanobacteria [1], and magnetosomes of magnetotactic 
bacteria [2]. Overexpression of viral membrane proteins 
can also result in the formation of cytoplasmic mem-
brane structures in bacteria [3, 4]. Furthermore, produc-
tion of intracellular membrane vesicles in Escherichia coli 
can be triggered by expression of Acholeplasma laidlawii 
lipid glycosyltransferases [5]. Outside of these intrigu-
ing examples, intracellular membranes are rare in the 
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majority of bacterial cells, making them attractive sys-
tems for cell-based vesicle production.
The only bacteriophages known to have a lipid enve-
lope around their protein capsids are the members of the 
Cystoviridae family [6]. Pseudomonas phage phi6 infects 
Gram-negative plant-pathogenic Pseudomonas species 
[7, 8] and is the type member of this family [9]. Phi6 has 
three double-stranded RNA genome segments (S, M, and 
L) inside its triple-layered virion [10, 11]. Around the 
innermost core is a nucleocapsid surface shell composed 
of protein P8 [12–14]. The lipid-protein envelope around 
the nucleocapsid [6] consists of phospholipids derived 
from the host cytoplasmic membrane (CM) [15] and the 
following five viral membrane proteins: the major enve-
lope protein P9, fusogenic protein P6, spike protein P3, 
putative holin protein P10, and minor membrane protein 
P13 [13, 16–18].
Phi6 has a lytic lifecycle [8, 19] and the envelope is 
acquired inside the host cytosol [20]. Several hypotheses 
have been presented for the mechanism of phi6 envel-
opment [21, 22] but the exact pathway is still unknown. 
Early studies on nonsense mutants of phage phi6 sug-
gested that the major envelope protein P9 and the non-
structural protein P12 are the only proteins needed for 
phi6 virion envelopment [23]. P12 and P9 are expressed 
consecutively from the S segment [24], and this genomic 
organization is highly conserved among known cystovi-
ruses [25]. P9 has a molecular weight of 9.5  kDa and a 
putative transmembrane region at amino acids 51–66 
[24]. In natural phi6 infection, P9 is likely to be delivered 
and attached into the CM via its transmembrane region. 
Recently, P9 was used as a fusion partner for eukaryotic 
membrane proteins to enhance their expression in an E. 
coli membrane [26].
How P12 facilitates viral envelopment is not known. 
However, several roles have been proposed, including 
assisting the other phi6 membrane proteins to the cor-
rect pathway [27], stabilizing membrane proteins, acting 
as a protease inhibitor [21], and a role as a lipid trans-
porter [22]. Co-expression of phi6 proteins P9 and P12 in 
Pseudomonas syringae leads to the formation of low-den-
sity P9 particles [21]. Sarin et al. [28] demonstrated that 
phi6-specific vesicles are also formed in E. coli bacteria 
expressing P8, P9, and P12. Lately, this E. coli system was 
used to produce synthetic lipid-containing scaffolds and 
to co-localize P9-tagged enzymes or marker proteins to 
such intracellular structures [29].
The aim of this study was to identify the minimum 
protein components needed for phi6-specific vesicle for-
mation in bacteria and the specific requirements for the 
localization of P9-tagged heterologous proteins into the 
vesicles. We demonstrate that phi6 P9 can trigger the 
formation of low-density membrane vesicles in E. coli 
in the absence of any other viral protein and that P9 is 
selectively incorporated into such vesicles. In addition, 
our data shows that P9 fusion proteins are directed into 
these membrane structures. However, the stable produc-
tion of the fusion proteins requires P12, which protects 
against proteolytic action. A bacterial vesicle production 
system based on phi6 provides the possibility to produce 
lipid vesicles containing heterologous proteins for differ-
ent biotechnological and biomedical applications.
Materials and methods
Bacterial strains and plasmids
Escherichia coli JM109 [30] was used as a cloning strain 
and E. coli BL21(DE3) [31] as an expression strain. Cells 
were grown at 37 °C at 200 rpm shaking in L-broth [1% 
(w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast, and 0.5% 
(w/v) sodium chloride] unless otherwise stated. 150 µg/
ml ampicillin, 25  µg/ml kanamycin and/or 50  µg/ml 
streptomycin were added to the cultivation media when 
bacteria contained pRSETa, pET28a + and/or pCDF-1b 
based plasmids, respectively (Table 1).
Pseudomonas phage phi6 S  segment genes 12 and 9 
were amplified using pLM659 [32] as a template in a 
polymerase chain reaction (PCR) (Tables  1 and 2). For 
protein expression, the amplification products were 
ligated to pET28a + or pCDF-1b vectors (Table 1). Genes 
encoding proteins P12 and P9 were cloned separately 
and consecutively under the T7 promoter. The resulting 
plasmids (pOL2, pDS4, and pOL5) (Table  1) were used 
for the expression of P9 and P12 in cis and in trans. Plas-
mid P9-GFP [26] is a derivative of the pRSETa vector and 
encodes P9 with a C-terminally fused green fluorescent 
protein (GFP) (Table 1).
Expression and purification of lipid‑protein vesicles
Expression and isolation of lipid-protein vesicles were 
based on protocols introduced by Sarin et  al. [28] and 
Laurinavičius et  al. [34]. E. coli BL21(DE3) cells were 
grown to an optical density at 550 nm  (OD550) of 0.6–0.8 
and expression of phi6-specific proteins was induced 
with 1  mM isopropyl β-d-1-thiogalactopyranoside 
Table 1 Plasmids
* pT7T3-19U (Pharmacia); pET28a + (Novagen); pCDF-1b (Novagen); pRSETa 
(Invitrogen)
Plasmid Vector* Proteins encoded Resistance Reference
pLM659 pT7T3-19U P8, P12, P9, and P5 Ampicillin [32]
pDS4 pCDF-1b P9 Streptomycin This study
pOL2 pET28a+ P12 Kanamycin This study
pOL5 pCDF-1b P12 and P9 Streptomycin This study
P9-GFP pRSETa P9-GFP fusion Ampicillin [26]
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(IPTG) for 20  h at room temperature (RT). Cells col-
lected by centrifugation were suspended in 20 mM Tris–
HCl pH 7.5, 150 mM NaCl and disrupted with a French 
press at 800  pounds  per square inch (psi), correspond-
ing to approximately 5.5 MPa. After centrifugation (Sor-
vall F-28/50 rotor, 8200g, 20 min, 4 °C), the vesicles were 
precipitated from the supernatant with 9% (w/v) poly-
ethylene glycol (PEG) 6000 and 5% (w/v) NaCl for 1 h at 
4  °C under magnetic stirring and collected by centrifu-
gation as above. The resulting pellet was washed gently 
with milli-Q water and dissolved overnight in 10  mM 
 KH2PO4, 1 mM  MgCl2 on ice. Any insoluble material was 
removed by centrifugation (Hitachi Koki himac CT15RE 
centrifuge, T15A61 rotor, 9600g, 10  min, 4  °C) prior to 
the following analyses. The PEG precipitation procedure 
was omitted when samples containing P9-GFP fusion 
protein were analyzed.
For flotation centrifugation, approximately 3 ml of the 
PEG-precipitated sample or the cleared lysate in approxi-
mately 77% (w/v) sucrose was loaded on a 0.5-ml cush-
ion of 80% (w/v) sucrose in 20  mM Tris–HCl pH 8.5, 
150  mM NaCl, 10  mM  MgCl2 buffer. The sample was 
covered with 2-ml layers of 57%, 48%, 39%, and 30% (w/v) 
sucrose solutions in the same buffer. Following flota-
tion centrifugation (Sorvall TH641 rotor, 210,000g, 22 h, 
20  °C unless otherwise stated), 1-ml fractions were col-
lected with a piston gradient fractionator (BioComp) and 
the pellet was resuspended in 1 ml of 68% (w/v) sucrose, 
20 mM Tris–HCl pH 8.5, 150 mM NaCl, 10 mM  MgCl2 
buffer. An additional rate-zonal centrifugation step (Sor-
vall TH641 rotor, 125,000g for 1 h 50 min at 20 °C) was 
performed before flotation centrifugation when higher 
vesicle purity was desired.
Microscopy methods
Escherichia coli BL21(DE3) thin sections were pre-
pared as follows: cells with selected plasmids (pDS4, 
pOL2, pCDF-1b; Table  1) were grown to  OD550 0.6–0.7 
and expression of phi6-specific membrane proteins was 
induced as described in “Expression and purification of 
lipid-protein vesicles”. Collected cells were suspended in 
L-broth and fixed with 2.5% (v/v) glutaraldehyde, 20 mM 
 KPO4 pH 7.2 in L-broth in foil at RT for 1 h. Cells were 
washed gently three times with 20 mM  KPO4 pH 7.2 in 
L-broth and the final glutaraldehyde-fixed cell pellet 
was stored with supernatant overnight on ice. The fixed 
cells were osmium-tetroxide treated, dehydrated, plas-
tic embedded in Epon, thin-sectioned, and post-stained 
with uranyl-acetate by the Electron Microscopy Unit of 
the University of Helsinki. The P9 vesicle fraction from 
the flotation centrifugation analysis was concentrated 
10× using Amicon Ultra-4, Ultracel 30  K concentrator 
(Merck Millipore Ltd., UFC803024), the concentrated 
sample, in 20  mM Tris–HCl pH 7.5, 150  mM NaCl, 
was applied on a carbon coated, glow discharged EM 
grid for 1 min, and stained with uranyl-acetate for 30 s. 
The thin sections and P9 vesicles were analyzed using 
transmission electron microscopy (TEM; Jeol JEM-
1400, 80,000  V). For the fluorescent microscopy E. coli 
BL21(DE3)(P9-GFP)(pOL5) cells were grown and pro-
tein expression induced as described in “Expression and 
purification of lipid-protein vesicles”. Suspension of the 
cell pellet in 20 mM Tris–HCl pH 7.5, 150 mM NaCl was 
visualized using Olympus BX50 microscope with FITC 
(fluorescein isothiocyanate) filter and visible light.
Analytical methods
Densities of the 1-ml fractions from the flotation centrif-
ugation analyses were determined from three independ-
ent experiments by measuring the weight of three 100 µl 
subfractions from each fraction. The fractions were pre-
cipitated with trichloroacetic acid (TCA) and analyzed 
by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE). The SDS-PAGE gels were stained 
with Coomassie, Sudan black, or both and imaged using 
a ChemiDoc Touch imager (BioRad) or used for West-
ern blotting. Polyclonal antibodies (pAb) against P12 
(1:13,333; GeneCust) and phi6 (1:2500) and a mono-
clonal antibody against GFP (1:25,000; ab291, Abcam) 
were used as primary antibodies. HRP-labeled anti-rab-
bit pAb (1:125,000; Sigma Aldrich) or anti-mouse pAb 
(1:5000; PI-2000; Vector Laboratories Inc.) were used as 
Table 2 Primers
* Melting temperatures (Tm) were calculated using the ThermoFisherScientific Tm calculator, which is based on the modified Breslauer’s thermodynamics method [33]
Primer Sequence Tm, °C* Plasmid
P9_5′_NcoI 5′-TAC AGT CCA TGG CTA TGC CAT TTC CTC TGG TAAAG-3′ 62.2 pDS4
P9_3′_HindIII 5′-TAG CAC AAG CTT AGG CCA GAA AAG GGATG-3′ 62.0 pDS4
P12_5′_NcoI 5′-ATA CCA TGG TTA TCG GTC TCC TGA AG-3′ 62.3 pOL2, pOL5
P12_3′_EcoRI 5′-TTA GAA TTC ATT ACG GAA CAT CCT TACG-3′ 60.0 pOL2
P9_3′_HindIII_R 5′-GCG CAA GCT TAG GCC AGA AAA GGG ATG TTG -3′ 66.2 pOL5
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secondary antibodies. Chemiluminescence was detected 
using a Western Lightning ECL Kit (Perkin-Elmer) and 
ChemiDoc Touch imager (BioRad) with 600  s of expo-
sure time. Mass spectrometric analyses of P12 were 
performed in the Proteomics Unit of the University of 
Helsinki using liquid-chromatography–mass spectrom-
etry × 2 (LC–MS/MS). Quantitative analyses of the EM 
thin sections was done using Aida Image Analyzer v 4.5.
Results
P9 induces vesicle formation in the absence of P12
Detection of spherical structures in E. coli thin sections
The phi6 major envelope protein P9 and the non-struc-
tural protein P12 are the minimum requirements for 
viral envelope formation in the Pseudomonas host [23]. 
To further investigate P9- and P12-driven vesicle forma-
tion [21, 28], we expressed P9 alone (pDS4) and together 
with P12 (pDS4 and pOL2; Table 1) in E. coli BL21(DE3). 
Thin-sectioned BL21(DE3) cells were analyzed by TEM 
(Fig.  1). Expression of P9 alone (Fig.  1a) or P9 together 
with P12 (Fig.  1b) resulted in formation of spherical 
structures not detected in the BL21(DE3)(pCDF-1b) con-
trol cells (Fig.  1c). These large, evenly stained, spherical 
areas appeared to be polarized and more abundant in 
cells expressing P9 only than in the cells producing both 
P9 and P12 (Fig. 1a, b; detected in 66 and 37 cells out of 
hundred cells, respectively). The areas of these struc-
tures varied from 0.01–0.72  µm2 (Fig.  1a, b). However, 
these numbers are likely underestimates as the putative 
P9-specific structures were not evenly distributed in the 
cells and the display of the structures strongly depends 
on the position of slicing. Also, it cannot be distinguished 
if an identified area is composed of multiple densely 
packed structures or present a single structure.
P9 vesicle detection by flotation centrifugation
Electron microscope analyses suggested that expression 
of P9 induces formation of intracellular membrane struc-
tures (Fig.  1). To clarify the nature of these structures, 
we analyzed the membrane fractions of the correspond-
ing E. coli cells using flotation centrifugation analysis. 
Lysed Gram-negative bacteria typically produce two light 
scattering zones in equilibrium centrifugation, namely 
an upper zone representing the CM and the lower zone 
representing the outer membrane (OM) [5, 35, 36]. Cor-
responding light scattering zones were detected when 
lysates of cells expressing P9 or control cells harboring 
the pCDF-1b vector were analyzed (Fig. 2a). Interestingly, 
the expression of P9 resulted in the formation of an addi-
tional membrane fraction, detected as a light scattering 
zone above the CM fraction (Fig. 2a). The density of this 
fraction was approximately 1.13  g/cm3 in sucrose, cor-
responding to a lipid-to-protein ratio of approximately 
1:1 (w/w; assuming a pure membrane protein den-
sity of 1.28  g/cm3 and a lipid density of 1.02  g/cm3 
[37]). The densities of the CM and OM fractions were 
approximately 1.17  g/cm3 and 1.20  g/cm3, respectively. 
We analyzed the light scattering, low-density fraction 
using TEM and detected spherical, vesicular structures 
approximately 100 nm in diameter (Fig. 2b). Only P9 and 
lipids were detected in these low-density upper fractions 
(Fig. 2c). These data confirms the presence of P9-specific 
lipid vesicles. P9 was also abundant in the CM fraction, 
supporting the idea that P9 is initially produced and 
delivered to the CM. However, the CM and OM fractions 
contained a plethora of other cell-derived background 
proteins, whereas the low-density fraction was composed 
almost merely of P9 and lipids (Fig. 2c).
Fig. 1 Thin sections of E. coli cells expressing P9 and P12. E. coli 
BL21(DE3) cells expressing phi6 proteins P9 and P12 were fixed with 
glutaraldehyde, embedded in Epon, thin sectioned, and analyzed by 
transmission electron microscopy (TEM). Representative TEM images 
of cells expressing the major envelope protein P9 from plasmid pDS4 
(a), P9 and the non-structural protein P12 from plasmids pDS4 and 
pOL2, respectively (b), and control cells containing vector plasmid 
pCDF-1b (c). Each scale bar represents 1 µm. The arrows in a and b 
point to structures specifically identified in cells expressing P9
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P12 does not associate with P9 vesicles
Flotation analysis of the lysates of cells expressing P9 
and P12 resulted in a similar pattern of light scattering 
zones as observed for the lysates of P9-expressing cells 
(Fig. 2a). Low-density light scattering material composed 
of P9 and lipids was detected irrespective of the expres-
sion system and the presence of P12 (Fig. 2c, d). Western 
blot analysis of the gels using anti-P12 antibody revealed 
two closely migrating P12-specific bands (Fig.  2d), both 
of which were confirmed to represent P12 by LC–MS/
MS analysis. P12 was not associated with the P9 vesi-
cle fractions but could be detected in the CM fractions 
(Fig. 2d). This suggests that P12 has affinity for lipids or 
proteins associated with the CM, but is not directly asso-
ciated with P9 vesicles that are predicted intermediates in 
the phi6 envelope assembly pathway. However, this result 
does not exclude the possibility that P12 interacts with 
P9 at the CM.
Purification of P9 vesicles
To further analyze the composition of the low-den-
sity P9 vesicles, we purified vesicles from lysates of E. 
coli BL21(DE3)(pOL5) cells expressing P12 and P9 in 
cis, using both rate-zonal and flotation centrifugation 
Fig. 2 Membrane fractions of cells expressing phi6 proteins P9 and P12. The phi6 major envelope protein P9 and non-structural protein P12 were 
co-expressed in E. coli overnight. Solid sucrose was added to PEG-precipitated cell lysates to obtain approximately 77% (w/v) sugar concentration, 
and the samples were analyzed by equilibrium flotation centrifugation (a–d). After centrifugation, light scattering was detected under visible 
light (a). The positions of the OM, CM, and P9 vesicle (V) fractions and their densities are indicated on the left, and the proteins expressed or the 
corresponding vector controls are indicated above the tube images (a). b Negatively stained P9 vesicles produced in E. coli BL21(DE3)(pDS4) 
analysed using TEM. The scale bar corresponds to 500 nm. c, d Analysis of the flotation gradient fractions (top panel) by SDS-PAGE. The plasmids 
used and proteins produced are presented on the left. The gels were stained with Coomassie and Sudan Black to identify proteins and lipids (L), 
respectively (c, bottom panel; d, middle panel) or by Western blotting using P12-specific antibodies (d, bottom panel). The position of the P9 vesicle 
fraction is indicated (V; top panels; c, d). Phi6 represents purified phi6 virions (c, d) and P12 purified recombinant P12 (d). The main structural 
proteins of phi6 (c, d) and the two mobility forms of the non-structural protein P12 (d) are indicated on the left. e P9 vesicles (V) were purified from 
PEG-precipitated E. coli BL21(DE3)(pOL5) lysates using rate-zonal and equilibrium flotation centrifugation at 4 °C. The plasmid used is presented 
above, and the main structural proteins of the phi6 standard on the left (e)
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(Fig.  2e). No cellular proteins could be detected in the 
uppermost fractions of purified P9 vesicles, indicating 
that formation of P9 vesicles is a highly selective process 
(Fig. 2e).
Introduction of heterologous P9‑GFP fusion protein
P9‑GFP is susceptible to protease degradation
Previously, the phi6 major envelope protein P9 was 
used as an expression partner to enhance heterolo-
gous membrane protein production in E. coli [26]. In 
this system, GFP was used as an indicator for proper 
folding of the expressed membrane proteins [26, 38]. 
We analyzed the effect of the GFP-tag on formation of 
P9-specific vesicles. Lysates of E. coli BL21(DE3) cells 
expressing the P9-GFP fusion protein were analyzed 
by flotation centrifugation analysis (Fig.  3a, b). The 
observed pattern of the light scattering zone was simi-
lar to that observed for the lysate of E. coli BL21(DE3) 
control cells, except for an intense green zone that 
appeared at the bottom of the tube (Fig. 3a). This sug-
gested that the expressed GFP was not associated with 
lipids (Fig.  3a). Western blot analysis using anti-GFP 
antibody revealed that the bottom fractions contained 
a GFP-specific polypeptide of approximately 30  kDa 
(Fig.  3b). This likely represents the 26.9  kDa GFP-tag, 
which is proteolytically cleaved from the 36.4  kDa 
P9-GFP fusion protein (Fig. 3b).
P12 facilitates P9‑GFP vesicle formation
To test the hypothesis that P12 could act as a protease 
inhibitor [21], we co-expressed P9-GFP with P12 and 
P9 (pOL5). This resulted in formation of a green light 
scattering zone in the flotation centrifugation analysis 
(Fig. 3a). The density of the collected green fraction was 
slightly higher than the density of the P9 vesicle (1.17 g/
cm3 versus 1.13  g/cm3) and corresponded to the den-
sity of the CM of Gram-negative bacteria (E. coli, 1.15–
1.17  g/cm3 [35]; P. syringae, 1.18  g/cm3 ± 0.02 [15]). 
The full-sized P9-GFP fusion protein (36.4  kDa) could 
be identified in these fractions by Western blot analy-
sis using anti-GFP antibody (Fig. 3c). Although both P9 
and P9-GFP were expressed in the cell, only the P9-GFP 
fusion protein was detected in the fractions (Fig.  3d). 
The expression of P12 and P9 separately with P9-GFP 
confirmed that the formation of the P9-GFP vesicle was 
dependent on P12 (Additional file 1).
Fig. 3 Expression of P9-GFP fusion protein. P9-GFP fusion protein was expressed alone or together with wild type P9 and the non-structural protein 
P12 in E. coli BL21(DE3) cells. Solid sucrose was added to the lysate (a–c) to obtain approximately 77% (w/v) sugar concentration for the equilibrium 
flotation centrifugation analysis. After flotation centrifugation, light scattering was detected under visible light (a). The positions of the P9 and 
P9-GFP vesicle fractions (V-P9 and V-P9-GFP, respectively), and the position of soluble GFP are indicated on the right. The proteins expressed are 
indicated above the tube images. BL21 indicates E. coli BL21(DE3) control cells (no phi6 protein expression). b, c Analysis of the flotation gradient 
fractions (top panel) by Western blotting using an anti-GFP antibody (bottom panel). The expressed proteins and the plasmids used are presented 
above. The position of the P9-GFP vesicle (V-P9-GFP) is indicated (c, top panel). The 40- and 30-kDa bands from MagicMark™ XP Western Protein 
standard (ThermoFisher Scientific) are indicated on the left (b and c; bottom panels). d Coomassie-stained SDS-PAGE gel of P9-GFP vesicles purified 
from E. coli BL21(DE3)(P9-GFP)(pOL5) cells by rate-zonal and equilibrium flotation centrifugation (42 h). Phi6 represents purified phi6 virions. The 
molecular weights of selected phi6 structural proteins are indicated on the left (d). e E. coli BL21(DE3)(P9-GFP)(pOL5) cells were visualized using 
Olympus BX50 microscope and FITC (fluorescein isothiocyanate) filter and visible light. The proteins expressed are indicated on the top, the arrows 
indicate fluorescent foci inside the cells
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Purification of P9‑GFP vesicles
To determine whether these vesicles are specific to 
P9-GFP and thus distinct from random CM vesicles, the 
P9-GFP vesicles produced in E. coli BL21(DE3)(P9-GFP)
(pOL5) were expressed and visualized by fluorescent 
microscope and purified using rate-zonal and flotation 
centrifugation. The purified P9-GFP vesicle fraction con-
tained predominantly the 36.4  kDa P9-GFP fusion pro-
tein (Fig.  3d) and E. coli cells expressing these P9-GFP 
vesicles contained fluorescent foci polarized to the ends 
of the cells (Fig. 3e).
Discussion
Phi6 P9 can induce vesicle formation in E. coli
In this study, we showed that the phage phi6 major enve-
lope protein P9 induces production of intracellular mem-
brane structures in E. coli in the absence of any other 
viral protein. Expression of P9 in E. coli resulted in the 
production of spherical cytoplasmic structures (Fig.  1). 
When the membranes of these cells were isolated it was 
possible to identify a low-density fraction distinct from 
the bacterial CM and OM (Fig.  2). This fraction con-
tained vesicles composed of P9 and lipids (Fig. 2b, c); no 
other proteins were detected (Fig. 2e). Thus, the vesicles 
produced in this system appeared to be more uniform in 
composition than those obtained previously in compara-
ble E. coli expression systems [5, 28]. The detected mem-
branous structures inside E. coli cells (Fig. 1) and the high 
P9 specificity of the vesicles (Fig. 2e) indicate that the P9 
vesicles are not simply byproducts of the cell lysis proce-
dure but separate membrane structures selectively pro-
duced within the cell due to the activity of P9.
P9‑GFP vesicle production is enhanced by P12
GFP was originally isolated from Aequorea jellyfish [39] 
and has been used in a wide range of biotechnological 
applications, including detection of recombinant protein 
expression, localization of proteins within cells, or as an 
indicator for the proper folding of membrane proteins 
[26, 29, 38]. We used a P9-GFP fusion protein to deter-
mine if it is possible to incorporate heterologous pro-
teins into the P9-specific vesicles. Previously, Myhrvold 
et  al. [29] detected fluorescent foci inside cells express-
ing a P9-YFP (yellow fluorescent protein) fusion protein 
and P12. However, it was not clear whether these foci 
were part of the CM or if there were cellular membrane 
proteins associated with P9-specific membrane patches. 
In our study, we could not isolate P9-GFP vesicles when 
P9-GFP was expressed in E. coli in the absence of other 
viral proteins (Fig.  3a). One possible explanation for 
this could be the relatively large size of GFP (26.9  kDa) 
compared to P9 (9.5  kDa), which could result in steric 
hindrance preventing potential interactions between 
neighboring P9 subunits and thus the formation of the 
vesicles. However, co-expression of P9 and P9-GFP did 
not result in the formation of P9-GFP vesicles (Addi-
tional file 1) and no P9 was associated with the P9-GFP 
vesicles produced by co-expressed P9, P12, and P9-GFP 
(Fig.  3d). Another possible explanation could be the 
instability of the fusion protein, as GFP fusion pro-
teins are prone to proteolysis [26, 40]. In support of this 
hypothesis, we detected a GFP-specific polypeptide of 
approximately 30 kDa in the bottom fractions of the flo-
tation centrifugation tubes. Interestingly, the addition of 
the non-structural protein P12 in the expression system 
rescued the full-length P9-GFP fusion protein (Fig. 3 and 
Additional file 1). Co-expression of P9-GFP, P9, and P12 
resulted in the formation of a floating GFP-containing 
fraction (Fig. 3a, c). The density of this fraction was simi-
lar to that of the CM fraction of Gram-negative bacteria 
[15, 35]. To exclude the possibility that P9-GFP was part 
of the normal CM, we analyzed the cells in fluorescent 
microscopy (Fig.  3e) and purified the P9-GFP vesicles 
using rate-zonal and equilibrium centrifugation (Fig. 3d). 
The cells had inner fluorescent foci and the P9-GFP was 
clearly enriched in the purified vesicles, suggesting that 
the P9-GFP vesicles were formed selectively and were not 
byproducts of mechanical CM disruption.
Conclusions
In this study we produced bacteriophage phi6-specific 
lipid-protein vesicles in E. coli BL21(DE3) cells using the 
phi6 major envelope protein P9 and the non-structural 
protein P12. Expression of P9, a small viral protein with 
a transmembrane region, triggered intracellular mem-
brane formation in bacterial cells that do not normally 
have internal membrane structures and thus likely do 
not possess mechanisms to support the production of 
such features. P9 could also direct a heterologous pro-
tein fused to P9 into membrane structures. However, the 
production of intact fusion protein was dependent on the 
co-expression of the non-structural protein P12, known 
to be involved in viral envelope biogenesis. In our E. coli 
expression system, P12 most likely acts as an inhibitor of 
proteolytic action or as a molecular chaperon that pro-
tects the full-sized P9-fusion protein. Thus, P12 may 
have potential use as a facilitator of recombinant mem-
brane protein production, although additional research 
is needed on this topic. The P9-based vesicle production 
system described here is an excellent tool to study the 
molecular mechanisms of biological vesicle formation. 
We envision that the system will likely have future use in 
biotechnology and biomedicine in applications such as 
drug or heterologous protein targeting and delivery.
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Additional file
Additional file 1. Expression of P9-GFP fusion protein with P9 and P12. 
P9-GFP fusion protein was expressed together with either wild type P9 
(a) or the non-structural protein P12 (b) in E. coli BL21(DE3) cells. Cells 
were collected and disrupted and solid sucrose was added to the cleared 
lysate to obtain approximately 77% (w/v) sugar concentration for the 
equilibrium flotation centrifugation analysis. The contents of the flotation 
centrifugation tubes were fractionated and the fractions were TCA pre-
cipitated and analyzed by Western blotting using an anti-GFP antibody. 
The expressed proteins and the plasmids used are presented above. The 
40- and 30-kDa bands from MagicMark™ XP Western Protein standard 
(ThermoFisher Scientific) are indicated on the left (bottom panel).
Abbreviations
CM: cytoplasmic membrane; GFP: green fluorescent protein; kDa: kilo dalton, 
1 dalton = atomic mass unit; LC–MS/MS: liquid-chromatography–mass spec-
trometry/mass spectrometry; OD550: optical density at 550 nm wavelength; 
OM: outer membrane; pAb: polyclonal antibody; PEG: polyethylene glycol; 
rpm: revolutions per minute; RT: room temperature; SDS-PAGE: sodium 
dodecyl sulfate polyacrylamide gel electrophoresis; TEM: transmission electron 
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